tetano
Editor, Senior Moderator
J Surg Case Rep
. 2022 Apr 11;2022(4):rjac076.
doi: 10.1093/jscr/rjac076. eCollection 2022 Apr.
Bronchopleural fistula due to cavitary pneumonia after SARS-CoV-2 infection treated with open thoracostomy
Leonid A Belyayev[SUP] 1 [/SUP], Sophia M Foroushani[SUP] 1 [/SUP], Daniel C Wiener[SUP] 1 [/SUP], Westyn Branch-Elliman[SUP] 1 [/SUP], M Blair Marshall[SUP] 2 [/SUP], Hassan A Khalil[SUP] 1 [/SUP]
Affiliations
Abstract
Severe coronavirus disease of 2019 (COVID-19) disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes substantial parenchymal damage in some patients. There is a paucity of literature describing the surgical management COVID-19 associated bronchopleural fistula after failure of medical therapy. We present the case of a 59-year-old woman with SARS-CoV-2 pneumonia, secondary bacterial pneumonia with bronchopleural fistula and radiographic and clinical evidence of disease refractory to medical therapy. After a course of culture-driven antimicrobial therapy and failure to improve following drainage with tube thoracostomy, she was treated successfully with Clagett open thoracostomy. After resolution of the bronchopleural fistula, the thoracostomy was closed and she was discharged home. In cases of severe COVID-19 complicated by bronchopleural fistula with parenchymal destruction, a tailored approach involving surgical management when indicated can lead to acceptable outcomes without significant morbidity.
. 2022 Apr 11;2022(4):rjac076.
doi: 10.1093/jscr/rjac076. eCollection 2022 Apr.
Bronchopleural fistula due to cavitary pneumonia after SARS-CoV-2 infection treated with open thoracostomy
Leonid A Belyayev[SUP] 1 [/SUP], Sophia M Foroushani[SUP] 1 [/SUP], Daniel C Wiener[SUP] 1 [/SUP], Westyn Branch-Elliman[SUP] 1 [/SUP], M Blair Marshall[SUP] 2 [/SUP], Hassan A Khalil[SUP] 1 [/SUP]
Affiliations
- PMID: 35422997
- PMCID: PMC9004406
- DOI: 10.1093/jscr/rjac076
Abstract
Severe coronavirus disease of 2019 (COVID-19) disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes substantial parenchymal damage in some patients. There is a paucity of literature describing the surgical management COVID-19 associated bronchopleural fistula after failure of medical therapy. We present the case of a 59-year-old woman with SARS-CoV-2 pneumonia, secondary bacterial pneumonia with bronchopleural fistula and radiographic and clinical evidence of disease refractory to medical therapy. After a course of culture-driven antimicrobial therapy and failure to improve following drainage with tube thoracostomy, she was treated successfully with Clagett open thoracostomy. After resolution of the bronchopleural fistula, the thoracostomy was closed and she was discharged home. In cases of severe COVID-19 complicated by bronchopleural fistula with parenchymal destruction, a tailored approach involving surgical management when indicated can lead to acceptable outcomes without significant morbidity.